CStone Pharmaceuticals Enters Licensing Agreement with Allist Pharmaceuticals for Gavreto in China
China-based CStone Pharmaceuticals (HKG: 2616) has announced a licensing agreement with Allist Pharmaceuticals Co., Ltd,...
Roche’s Lymphoma Therapy Columvi Receives NMPA Approval for Adult Patients with Relapsed DLBCL
Swiss pharmaceutical giant Roche (SWX: ROG) has announced that it has received market approval from...
Eccogene Secures Exclusive Licensing Deal with AstraZeneca for GLP-1 Agonist ECC5004
Sino-US firm Eccogene Inc. has entered into an exclusive licensing agreement with UK pharmaceutical giant...
Sandoz Enters Euro Debt Market with $2.1 Billion Eurobond Issuance
Switzerland-based Sandoz (SWX: SDZ), a leader in the generics and biosimilars market, has successfully entered...
Janssen Presents Real-World Data on Tremfya’s Efficacy in Treatment-Resistant Psoriatic Arthritis
Johnson & Johnson’s (J&J; NYSE: JNJ) pharmaceutical unit, Janssen, has presented real-world efficacy data for...
Zhejiang Boner Medical Secures Over RMB 800 Million in Pre-IPO Financing for Strategic Expansion
Zhejiang Boner Medical Investment Management Co., Ltd., known as Bang-er Orthopedics, a leading hospital investment...
ImmuneOnco Biopharmaceuticals’ Timdarpacept (IMM01) Earns Orphan Drug Designation for CMML
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd (HKG: 1541) has announced that it has received orphan drug...
Lifetech Scientific Corporation Receives NMPA Approval for Peripheral Thrombus Suction Catheter
Lifetech Scientific Corporation (HKG: 1302), a China-based medical device company, has announced that it has...
Bayer’s Q3 2023 Financial Report: A Mixed Bag with Consumer Health Driving Growth
Germany-based major Bayer (ETR: BAYN) published its financial report for the third quarter of 2023,...
Viatris Inc. Reports Q3 2023 Global Net Sales Growth of 1% and Highlights from Earnings Call
US-based generics giant Viatris Inc., (NASDAQ: VTRS) has released its financial results for the third...
Abbisko Therapeutics’ CD73 Inhibitor ABSK051 Clears for Phase I Clinical Trial in China
Shanghai-based biotech Abbisko Therapeutics Co., Ltd (HKG: 2256) has announced that it has received approval...
US FDA Approves HutchMed and Takeda’s Fruzaqla for Metastatic Colorectal Cancer Treatment
The US Food and Drug Administration (FDA) has granted approval to HutchMed (NASDAQ: HCM) and...
Suzhou Porton Biologics Partners with BioMap to Enhance AAV Vector Design in Gene Therapy
Suzhou Porton Biologics Ltd, a China-based Contract Development and Manufacturing Organization (CDMO), has entered into...
CIIE 2023: Danaher, Boehringer-Ingelheim, Merck, J&J, BeiGene, and Fosun Pharma Announce China Partnerships
The 6th China International Import Expo (CIIE) held in Shanghai this week has been a...
Zymeworks and BeiGene Terminate Licensing Agreement for ZW49 ADC
Zymeworks Inc. (NASDAQ: ZYME), a Canada-based biotech company, has announced in its Q3 financial report...
Worg Pharmaceuticals Expands into Spain with Acquisition of Diater for EUR 150 Million
Worg Pharmaceuticals, a Hangzhou-based developer of allergic drugs, has formally entered the Spanish market by...
Janssen’s Nipocalimab Shows Promising Results in Phase II Rheumatoid Arthritis Trial
The Janssen unit of Johnson & Johnson (J&J; NYSE: JNJ) has announced the results of...
Gilead Reports Q3 2023 Financials with 1% YOY Revenue Increase and Updates 2023 Outlook
Gilead (NASDAQ: GILD) has released its financial results for the third quarter of 2023, showing...
AstraZeneca Expands China Presence with Over 30 Agreements at CIIE
At the 6th China International Import Expo (CIIE) in Shanghai, UK-based pharmaceutical giant AstraZeneca plc...
Moderna Initiates Construction of First China-Based Pharmaceutical Plant in Shanghai
S-based mRNA specialist, Moderna (NASDAQ: MRNA), has commenced construction on its inaugural pharmaceutical facility in...